Sign in
4

Changes in Ownership

MYRIAD GENETICS INC Filed Acc 0001628280-25-010136

Chief Commercial Officer acquired 12,758 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Verratti Mark Chief Commercial Officer 2025-02-07 Grant or award +12,758 302,035 D
Loading xslF345X05/wk-form4_1741134675.xml…